Abstract
The prevalence of hyperthyroidism owing to Graves1 disease is increasing among urban black South Africans. Thyroid-associated ophthalmopathy is often observed in this context, but its pathogenesis remains unclear. No close relationship has been noted between antiflavoprotein (Fp) antibodies or thyrotropin receptor antibodies and ocular involvement in black patients. We measured serum antibodies against eye muscle and orbital connective tissue antigens in black patients with Graves1 disease, correlating them with eye signs. Of 11 patients with clinical ophthalmopathy, 2 (18%) had antibodies against collagen type XIII, 3 (27%) against flavine adenine dinucleotide (FAD), 1 (9%) against Fp, and 4 (35%) against G2s. Antibody prevalences in eight patients without clinical ophthalmopathy were 12.5% for collagen XIII, 12.5% for FAD, 25% for Fp and 0% for G2s. These differences were not statistically significant. None of the individual mean antibody levels were significantly different between the two subgroups of thyrotoxic patients. Serum antibody levels were negative in 10 black South African controls. In summary, eye muscle and orbital connective tissue antibodies were found in small proportions of patients with Graves1 disease with no close relationship of any antibody to eye signs. Thus, a substantial proportion of black South Africans with overt clinical ophthalmopathy remains in whom currently availabe serologic tests are unhelpful for screening and laboratory confirmation.
Similar content being viewed by others
References
Kalk, W. J. (1981). East Afr. Med. J. 58, 109–116.
Mengistu, M. (1993). Ethiop. Med. J. 3, 25–36.
Modebe, O. (1995). Afr. J. Med. Med. Sci. 24, 347–351.
Zouvanis, M., Panz, V. R., Kalk, W. J., and Joffe, B. I. (1998). J. Endocrinol. Invest. 21, 771–774.
Joffe, B. L., Gunji, K., Panz, V., Ackrell, B., et al. (1998). Thyroid 8, 1023–1027.
Panz, V. R., Raal, F. J., Wall, J. R., and Joffe, B. I. (2000). Endocrine 12, 21–24.
Salvi, M., Miller, A., and Wall, J. R. (1988). FEBS Lett. 232, 135–139.
Wu, Y. I., Clarke, E. M., and Shepherd, P. (1998). Thyroid 8, 167–174.
Kubota, S., Gunji, K., Ackrell, B. A., et al. (1998). J. Clin. Endocrinol. Metab. 83, 443–447.
Gunji, K., De Bellis, A., Kubota, S., et al. (1999). J. Clin. Endocrinol. Metab. 84, 1255–1262.
Gunji, K., De Bellis, A., Li, A. W., et al. (2000). J. Clin. Endocrinol. Metab., 85, 1641–1647.
Pihlajaniemi, T. and Rehn, M. (1995). Prog. Nucleic Acid Res. Mol. Biol. 50, 225–262.
Hagg, P., Rehn, M., Huhtala, P., Vaisanen, T., Tamminen, M., and Pihlajaniemi, T. (1998), J. Biol. Chem. 273, 15,590–15,597.
Wall, J. R., Blanchard, M. E., West, K., and Pihlajaniemi, T. (1999). Paper presented at the 72nd Annual meeting of the American Thyroid Association (abstract). Palm Springs, FL.
Soloyeva, T. P. (1989). Orbit 3, 193–198.
Panz, V. R., Kalk, W. J., Zouvanis, M., and Joffe, B. I. (2000). Diabetic Med., 17, 524–527.
Committees of the American, European, Asia-Oceania, and Latin America Thyroid Associations. (1992). Thyroid 2, 235–236.
Miller, A., Sikorska, H., Salvi, M., and Wall, J. R. (1986). Acta Endocrinol. 113, 514–522.
Kapusta, M., Salvi, M., Triller, H., Gardini, E., Bernard, N., and Wall, J. R. (1990). Autoimmunity 7, 33–40.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Joffe, B.J., Panz, V.R., Yamada, M. et al. Thyroid-associated ophthalmopathy in black South Africans with Graves' disease. Endocr 13, 325–328 (2000). https://doi.org/10.1385/ENDO:13:3:325
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:13:3:325